Press-release for stocks

Prices are updated after-hours

save search

Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Under Temporary Symbol RXMDD
Published: 2022-12-30 (Crawled : 15:00) - globenewswire.com
RXMD 4 | $3.1525 74.18% 2.7K

Retail Trade

| 10069.49% | O: 916.95% H: 2230.0% C: 2066.67%

PARTY CITY SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Party City To Contact Him Directly To Discuss Their Options
Published: 2023-09-27 (Crawled : 22:00) - prnewswire.com
PRTYQ | $0.004 200.0% 28K

n/a

| 334.78% | O: -86.96% H: 1566.67% C: 833.33%
city

Week in Review: August 11, 2023
Published: 2023-08-14 (Crawled : 15:20) - myfw.com
FRCB | $0.0131 6.87% 570K

n/a

| -96.45% | O: -87.1% H: 712.5% C: 700.0%
week

Clubhouse Media Group, Inc. Closes Promo Deal With Rob Gronkowski, Four-Time Super Bowl Champion
Published: 2022-06-22 (Crawled : 13:00) - prnewswire.com
CMGR | $0.0002 -50.0% 22M

Health Care and Social Assistan...

| -92.0% | O: 12.0% H: 671.43% C: 246.43%
media deal

Avera Health and Theralink® Technologies Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
THER | $0.0014 85.71% 5.2M

n/a

| -99.76% | O: -80.0% H: 400.0% C: 300.0%
theralink health care collaboration cancer

Dais Shares Summary of Its Progress in 2022 With a Glimpse Into 2023
Published: 2023-01-17 (Crawled : 18:00) - globenewswire.com
DLYT | $0.012 71.67% 10K

| -78.0% | O: -79.0% H: 366.67% C: 366.67%

Tempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
Published: 2023-10-10 (Crawled : 20:00) - globenewswire.com
TPST | $3.25 4.17% 4.0% 550K

Manufacturing

| 1300.26% | O: 817.71% H: 358.69% C: 358.69%
tpst-1120 report global study

Tempest Adopts Limited Duration Stockholder Rights Plan
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
TPST | $3.25 4.17% 4.0% 550K

Manufacturing

| 1300.26% | O: 817.71% H: 358.69% C: 358.69%

Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
TPST | $3.25 4.17% 4.0% 550K

Manufacturing

| 1300.26% | O: 817.71% H: 358.69% C: 358.69%
tpst-1120 arm study

Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Published: 2020-12-01 (Crawled : 22:08) - globenewswire.com
EARS | $3.02 0%

Health Technology

| 172.07% | O: 31.53% H: 352.05% C: 258.22%
positive injection sars-cov-2 infections in vitro

Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Published: 2021-03-05 (Crawled : 15:00) - biospace.com/
EYES | $4.14 -0.24% 3.14%

Health Technology

| 189.51% | O: 60.14% H: 331.88% C: 152.84%
fda fda approval retina approval

Trevena Announces Approval of OLINVYK in China
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
TRVN F | $0.6344 1.49% 1.47% 100K

Health Technology

| -0.19% | O: 23.32% H: 322.19% C: 300.31%
approval olinvyk china

Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%
Published: 2023-02-23 (Crawled : 13:20) - globenewswire.com
OCEA | $0.5601 -15.27% -18.01% 490K

| -88.34% | O: 34.1% H: 312.43% C: 67.44%
lung melanoma glioblastoma

Applied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction
Published: 2021-02-09 (Crawled : 12:00) - biospace.com/
AUVI | $0.1076 -4.69% -4.93% 1.9M

Health Technology

| -97.9% | O: 73.75% H: 297.56% C: 119.0%
acquisition platform

iFresh Announces NASDAQ Delisting
Published: 2021-11-22 (Crawled : 19:00) - globenewswire.com
IFMK | $0.0006 49933.33% 150

Retail Trade

| -99.88% | O: -74.5% H: 292.08% C: 180.0%
nasdaq

Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
AMAM 4 | $12.67 5.32% 5.05% 870K

Professional, Scientific, and T...

| 2986.12% | O: 185.44% H: 288.03% C: 288.03%
arx788 treatment breast positive cancer her2- her2 metastatic breast cancer

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Published: 2022-03-21 (Crawled : 13:00) - biospace.com/
NRSN | $0.7944 9.57% 8.74% 1.2M

| -32.69% | O: 39.74% H: 275.23% C: 185.78%
treatment fda als clearance therapeutics fda clearance primec

iCoreConnect Announces Clarification Regarding Trading of Common Stock, Warrants and Preferred Stock
Published: 2023-08-28 (Crawled : 21:00) - globenewswire.com
ICCT | $0.9951 -6.12% -6.52% 120K

Professional, Scientific, and T...

| 401.78% | O: 944.39% H: 275.0% C: 182.0%

Motorsport Games Announces Debt-for-Equity Exchange with Motorsport Network
Published: 2023-01-30 (Crawled : 21:00) - globenewswire.com
MSGM | $2.41 -3.98% -4.15% 7K

| -4.94% | O: 182.13% H: 271.97% C: 188.41%
network games

Genetic Technologies Provides Update on COVID-19 Disease Severity Test
Published: 2020-07-15 (Crawled : 22:16) - globenewswire.com
GENE | $0.5985 -4.24% -4.43% 66K

Health Technology